Publicaciones en las que colabora con María Victoria Mateos Manteca (3)

2024

  1. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

    Blood, Vol. 143, Núm. 7, pp. 597-603

2021

  1. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 6, pp. 801-812

2012

  1. Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: The Spanish experience

    Leukemia and Lymphoma, Vol. 53, Núm. 9, pp. 1714-1721